Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Der Urologe. Ausg. A
|
November 10, 2019
[Influence of immunomodulators on urological imaging]
F Peisen, W Thaiss, N Tietze, et al.
Der Urologe. Ausg. A
|
February 14, 2013
[Urinary incontinence in the elderly: what can and should be done?]
B Amend, S Kruck, J Bedke, et al.
World Journal of Urology
|
March 10, 2009
Economic aspects of bladder cancer: what are the benefits and costs?
K D Sievert, B Amend, U Nagele, et al.
Der Urologe. Ausg. A
|
March 12, 2014
[Cell-based therapy to treat stress urinary incontinence: which cell type at what cost?]
M Vaegler, L A DaSilva, K Benz, et al.
Der Urologe. Ausg. A
|
November 10, 2012
[New treatment strategies for male lower urinary tract symptoms]
L F Arenas da Silva, M Schönthaler, F Cruz, et al.
Der Urologe. Ausg. A
|
October 28, 2009
[Second-line therapy of idiopathic detrusor overactivity. Sacral neuromodulation and botulinum toxin A]
B Amend, D Castro-Diaz, E Chartier-Kastler, et al.
Der Urologe. Ausg. A
|
February 13, 2007
[Value of stem cell therapy for the treatment of stress incontinence. Current status and perspectives]
K-D Sievert, B Amend, M Renninger, et al.
World Journal of Urology
|
August 9, 2011
Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma
B Amend, J Hennenlotter, M Scharpf, et al.
World Journal of Urology
|
November 17, 2016
First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy
S Kaufmann, J Mischinger, B Amend, et al.
Minerva Ginecologica
|
February 16, 2013
Different surgical approaches for stress urinary incontinence in women
J Mischinger, B Amend, C Reisenauer, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Der Urologe. Ausg. A
|
November 10, 2019
[Influence of immunomodulators on urological imaging]
F Peisen, W Thaiss, N Tietze, et al.
Der Urologe. Ausg. A
|
February 14, 2013
[Urinary incontinence in the elderly: what can and should be done?]
B Amend, S Kruck, J Bedke, et al.
World Journal of Urology
|
March 10, 2009
Economic aspects of bladder cancer: what are the benefits and costs?
K D Sievert, B Amend, U Nagele, et al.
Der Urologe. Ausg. A
|
March 12, 2014
[Cell-based therapy to treat stress urinary incontinence: which cell type at what cost?]
M Vaegler, L A DaSilva, K Benz, et al.
Der Urologe. Ausg. A
|
November 10, 2012
[New treatment strategies for male lower urinary tract symptoms]
L F Arenas da Silva, M Schönthaler, F Cruz, et al.
Der Urologe. Ausg. A
|
October 28, 2009
[Second-line therapy of idiopathic detrusor overactivity. Sacral neuromodulation and botulinum toxin A]
B Amend, D Castro-Diaz, E Chartier-Kastler, et al.
Der Urologe. Ausg. A
|
February 13, 2007
[Value of stem cell therapy for the treatment of stress incontinence. Current status and perspectives]
K-D Sievert, B Amend, M Renninger, et al.
World Journal of Urology
|
August 9, 2011
Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma
B Amend, J Hennenlotter, M Scharpf, et al.
World Journal of Urology
|
November 17, 2016
First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy
S Kaufmann, J Mischinger, B Amend, et al.
Minerva Ginecologica
|
February 16, 2013
Different surgical approaches for stress urinary incontinence in women
J Mischinger, B Amend, C Reisenauer, et al.
Page
of 3